To bnAb or Not to bnAb: Defining Broadly Neutralising Antibodies Against HIV-1

To bnAb or Not to bnAb: Defining Broadly Neutralising Antibodies Against HIV-1

Since their discovery, antibodies capable of broad neutralisation have been at the forefront of HIV-1 research and are of particular interest due to in vivo passive transfer studies demonstrating their potential to provide protection. Currently an exact definition of what is required for a monoclona...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Sarah A. Griffith, Laura E. McCoy
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	Frontiers Media S.A. 2021-10-01
Sraith:	Frontiers in Immunology
Ábhair:	HIV-1 broadly neutralising antibody somatic hypermutation complementary determining region epitope
Rochtain ar líne:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.708227/full

Míreanna comhchosúla

Understanding the Determinants of BnAb Induction in Acute HCV Infection
de réir: Alexander P. Underwood, et al.
Foilsithe / Cruthaithe: (2018-11-01)

The Mechanism of bnAb Production and Its Application in Mutable Virus Broad-Spectrum Vaccines: Inspiration from HIV-1 Broad Neutralization Research
de réir: Xinyu Zhang, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Prevalence of resistance-associated viral variants to the HIV-specific broadly neutralising antibody 10-1074 in a UK bNAb-naïve population
de réir: Panagiota Zacharopoulou, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity.
de réir: Caio Foulkes, et al.
Foilsithe / Cruthaithe: (2025-01-01)

The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention
de réir: Jannifer Jasmin Thavarajah, et al.
Foilsithe / Cruthaithe: (2024-06-01)

OP 8.6 – 00166 Autologous neutralizing antibody responses in bnAb-treated rhesus macaques
de réir: K. Bar, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana
de réir: Natasha O. Moraka, et al.
Foilsithe / Cruthaithe: (2023-10-01)

HIV Co-Receptor Usage, Broadly Neutralising Antibodies, and Treatment
de réir: Nina Lin, et al.
Foilsithe / Cruthaithe: (2019-07-01)

Introduction of the YTE mutation into the non-immunogenic HIV bnAb PGT121 induces anti-drug antibodies in macaques.
de réir: Yvonne J Rosenberg, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination
de réir: Carla Nel, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Contribution of rare mutational outcomes to broadly neutralizing antibodies
de réir: Feng Anqi, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Mechanisms of Rhinovirus Neutralisation by Antibodies
de réir: Lila Touabi, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection
de réir: Kahlio Mader, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Susceptibility to neutralization by bnAbs orrelates with infected cell binding for a panel of clade B HIV reactivated from latent reservoirs
de réir: Y. Ren, et al.
Foilsithe / Cruthaithe: (2017-12-01)

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials
de réir: Yunda Huang, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
de réir: Lok Bahadur Shrestha, et al.
Foilsithe / Cruthaithe: (2021-09-01)

Replacing serum with dried blood microsampling for pharmacokinetics, viral neutralisation and immunogenicity bioanalysis supporting future paediatric development of RSM01, a candidate respiratory syncytial virus neutralising monoclonal antibody
de réir: Joleen T. White, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants
de réir: George W. Carnell, et al.
Foilsithe / Cruthaithe: (2023-02-01)

Corrigendum: The Effects of Framework Mutations at the Variable Domain Interface on Antibody Affinity Maturation in an HIV-1 Broadly Neutralizing Antibody Lineage
de réir: Jeffrey O. Zhou, et al.
Foilsithe / Cruthaithe: (2020-11-01)

The Effects of Framework Mutations at the Variable Domain Interface on Antibody Affinity Maturation in an HIV-1 Broadly Neutralizing Antibody Lineage
de réir: Jeffrey O. Zhou, et al.
Foilsithe / Cruthaithe: (2020-07-01)

Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application
de réir: Alexander Hargreaves, et al.
Foilsithe / Cruthaithe: (2021-09-01)

Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection
de réir: Mader, K, et al.
Foilsithe / Cruthaithe: (2024)

Passive immunization with influenza haemagglutinin specific monoclonal antibodies
de réir: Rajeev Rudraraju, et al.
Foilsithe / Cruthaithe: (2018-11-01)

Different Somatic Hypermutation Levels among Antibody Subclasses Disclosed by a New Next-Generation Sequencing-Based Antibody Repertoire Analysis
de réir: Kazutaka Kitaura, et al.
Foilsithe / Cruthaithe: (2017-05-01)

Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs), given to HIV-1 exposed, uninfected neonates and infants: study protocol for a phase I trial
de réir: Ameena Goga, et al.
Foilsithe / Cruthaithe: (2024-07-01)

CD8 Effector T Cells Function Synergistically With Broadly Neutralizing Antibodies to Enhance Suppression of HIV Infection
de réir: Rebecca T. Veenhuis, et al.
Foilsithe / Cruthaithe: (2021-07-01)

The expanding array of HIV broadly neutralizing antibodies
de réir: Laura E. McCoy
Foilsithe / Cruthaithe: (2018-10-01)

Mapping of Recognition Sites of Monoclonal Antibodies Responsible for the Inhibition of Pneumolysin Functional Activity
de réir: Indre Kucinskaite-Kodze, et al.
Foilsithe / Cruthaithe: (2020-07-01)

Neutralising Neurophobia
de réir: Greg Lamb
Foilsithe / Cruthaithe: (2018-03-01)

P04-39. Recognizing a dynamic HIV-1 target: a structural look at the interaction between bnAb 2F5 and varying gp41 MPER sequences
de réir: Pai EF, et al.
Foilsithe / Cruthaithe: (2009-10-01)

Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection caseResearch in context
de réir: Takeo Kuwata, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)
de réir: Benjamin Meyer, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Poly- and autoreactivity of HIV-1 bNAbs: implications for vaccine design
de réir: Joel Finney, et al.
Foilsithe / Cruthaithe: (2018-07-01)

Schmallenberg virus neutralising antibody responses in sheep
de réir: Scott Jones, et al.
Foilsithe / Cruthaithe: (2019-11-01)

A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls
de réir: James H. McMahon, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia
de réir: Sean A. Lynch, et al.
Foilsithe / Cruthaithe: (2021-08-01)

Identification of Subject-Specific Immunoglobulin Alleles From Expressed Repertoire Sequencing Data
de réir: Daniel Gadala-Maria, et al.
Foilsithe / Cruthaithe: (2019-02-01)

Production of Autoreactive Heavy Chain-Only Antibodies in Systemic Lupus Erythematosus
de réir: Shu Xu, et al.
Foilsithe / Cruthaithe: (2020-05-01)

Åland Demilitarisation and Neutralisation – International Lessons
de réir: Robert Rydberg
Foilsithe / Cruthaithe: (2022-03-01)

Antibody Heavy Chain Variable Domains of Different Germline Gene Origins Diversify through Different Paths
de réir: Ufuk Kirik, et al.
Foilsithe / Cruthaithe: (2017-11-01)